Introduction Inflammatory reactions, including those mediated by the NLRP3 inflammasome, maintain the body's homeostasis by removing pathogens, repairing damaged tissues, and adapting to stressed environments. However, uncontrolled activation of the NLRP3 inflammasome tends to cause various diseases using different mechanisms. Recently, many inhibitors of the NLRP3 inflammasome have been reported and many are being developed. In order to assess their efficacy, specificity, and mechanism of action, the screening process of inhibitors requires various types of cell and animal models of NLRP3-associated diseases.Areas covered In the following review, the authors give an overview of the cell and animal models that have been used during the research and development of various inhibitors of the NLRP3 inflammasome.Expert opinion There are many NLRP3 inflammasome inhibitors, but most of the inhibitors have poor specificity and often influence other inflammatory pathways. The potential risk for cross-reaction is high; therefore, the development of highly specific inhibitors is essential. The selection of appropriate cell and animal models, and combined use of different models for the evaluation of these inhibitors can help to clarify the target specificity and therapeutic effects, which is beneficial for the development and application of drugs targeting the NLRP3 inflammasome.Two new compounds (1 and 2), belonging to C-20 oxygenated ent-kauranes-type diterpenoids, were identified from the aerial parts of Isodon serra. Their structures were elucidated by extensive analysis of HRESI-MS and NMR spectroscopic data. Both these two compounds possess a common 7,20-epoxy-ent-kauranes skeleton with a hydroxyl group rarely occurring at C-13. Compounds 1 and 2 were evaluated for their cytotoxic activity against Hela-60 and HepG2 as well as the antibacterial activity against Staphylococcus aureus, Bacillus cereus and Escherichia coli.Diabetic nephropathy (DN) is a frequent and severe microvascular complication associated with diabetes mellitus. A novel melanin-based biomimic photothermal nanoparticles, glucose-PEG2000-DSPE ligand modified red blood cell membrane vesicle encapsulated melanin (Glu-RBCm-melanin) was applied for diabetic nephropathy. Our results of renal targeting evaluation showed that Glu-RBCm-melanin could be specifically transported by over-expressed glucose transporter 1 (GLUT1) on membrane of glomerular mesangial cells and achieve excellent kidney targeted drug delivery. In addition, the results of photothermal therapy in DN rats demonstrated that Glu-RBCm-melanin could promote glomerular mesangial cell apoptosis and restrain glomerular mesangial cell hyperproliferation after near-infrared irradiation to protect the kidney as a therapeutic drug for diabetic nephropathy. Retrospective cohort study. The OF classification is a new classification for osteoporotic vertebral fractures. The aim of this study was to clarify the relationship between preoperative OF subgroups and the postoperative outcome after kyphoplasty in patients with such fractures. Patients who underwent kyphoplasty of a single osteoporotic vertebral fracture were included and divided into groups according to the OF subgroups. Pre- and postoperative plain radiographs were analyzed in regard to the restoration of vertebral body height and local kyphotic angle (LKA). Additionally, clinical data including pre- and postoperative Visual Analogue Scale pain scores was documented. The clinical and radiological results were compared pre- and postoperatively within groups and between groups. A total of 156 patients from OF subgroups 2 to 4 were included (OF 2 n = 58; OF 3 n = 36; OF 4 n = 62). Patients from all groups experienced significant pain relief postoperatively ( < .001). Patients with OF 2 fractures showed a repositioning of the vertebral body height in the anterior and middle portions (both < .001), but no significant improvement in LKA. For OF 3 and 4 fractures, there was a significant restoration of vertebral body height ( < .001 for both) and a significant improvement of LKA ( < .001 for both). The highest average restoration was noted in the OF 4 group. A higher OF subgroup is related to a higher radiological benefit from kyphoplasty. https://www.selleckchem.com/products/tulmimetostat.html This confirms that the OF classification is an appropriate tool for the preoperative assessment of osteoporotic fractures. A higher OF subgroup is related to a higher radiological benefit from kyphoplasty. This confirms that the OF classification is an appropriate tool for the preoperative assessment of osteoporotic fractures. Life story books in dementia are used as a part of person-centred care. Whilst the current literature demonstrates associations between completing life story books and increased well-being, little is known about the process and how it is experienced by individuals living with dementia. Life stories are often created with a loved one, such as a partner or spouse; however, further research is required to explore experiences of life story work as a shared endeavour. Furthermore, the use of technology to create life stories is growing, with little known about how digital elements are experienced. This study aimed to understand these gaps by exploring the shared experiences of individuals with dementia and their partner/spouse creating a digital life story book. Four couples participated in the six-week creation of their digital life story book. Following this, qualitative data relating to couples' experiences were collected via semi-structured interviews. Thematic analysis was used to interpret data and ideces before considering a digital approach. To determine the feasibility and safety of aerobic training with an arm crank ergometer and its effectiveness in improving functional capacity and gait in patients with recent hip fracture. Randomized, controlled, assessor-blinded pilot study, with intention-to-treat analysis. Inpatients, rehabilitation department. 40 patients with hip fracture surgically treated. Training group performed aerobic exercise with an arm crank ergometer (15 sessions, 30 minutes/day) at an intensity of 64% to 76% of maximum heart rate, in addition to conventional inpatient rehabilitation. Primary outcome was the feasibility (including eligibility rate, recruitment rate, number of drop-outs and adverse events, adherence). Secondary measures were the Timed Up and Go test, ability to walk independently, muscle torque of knee extensors of fractured and non-fractured leg, Functional Independence Measure. Mostly due to pre-existing disability and fracture type, only 40/301 (13%) patients were eligible (age 84.6 ± 7.6 years, 75% female); all agreed to participate and 90% completed the trial, without adverse events.